These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23463331)

  • 1. PSMA as a target for radiolabelled small molecules.
    Eder M; Eisenhut M; Babich J; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2013 Jun; 40(6):819-23. PubMed ID: 23463331
    [No Abstract]   [Full Text] [Related]  

  • 2. New Strategies in Prostate Cancer: Prostate-Specific Membrane Antigen (PSMA) Ligands for Diagnosis and Therapy.
    Haberkorn U; Eder M; Kopka K; Babich JW; Eisenhut M
    Clin Cancer Res; 2016 Jan; 22(1):9-15. PubMed ID: 26728408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges.
    Rowe SP; Gorin MA; Allaf ME; Pienta KJ; Tran PT; Pomper MG; Ross AE; Cho SY
    Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):223-30. PubMed ID: 27136743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intense PSMA-expression using (68)Ga-PSMA PET/CT in a paravertebral schwannoma mimicking prostate cancer metastasis.
    Rischpler C; Maurer T; Schwaiger M; Eiber M
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):193-194. PubMed ID: 26502982
    [No Abstract]   [Full Text] [Related]  

  • 5. Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer.
    Hillier SM; Maresca KP; Femia FJ; Marquis JC; Foss CA; Nguyen N; Zimmerman CN; Barrett JA; Eckelman WC; Pomper MG; Joyal JL; Babich JW
    Cancer Res; 2009 Sep; 69(17):6932-40. PubMed ID: 19706750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancer.
    Barrio M; Fendler WP; Czernin J; Herrmann K
    Expert Rev Mol Diagn; 2016 Nov; 16(11):1177-1188. PubMed ID: 27679869
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
    Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [
    Green MA; Hutchins GD; Bahler CD; Tann M; Mathias CJ; Territo W; Sims J; Polson H; Alexoff D; Eckelman WC; Kung HF; Fletcher JW
    Mol Imaging Biol; 2020 Jun; 22(3):752-763. PubMed ID: 31429050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between PSA kinetics and PSMA-PET in prostate cancer restaging: A meta-analysis.
    Pereira Mestre R; Treglia G; Ferrari M; Pascale M; Mazzara C; Azinwi NC; Llado' A; Stathis A; Giovanella L; Roggero E
    Eur J Clin Invest; 2019 Mar; 49(3):e13063. PubMed ID: 30580449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [¹⁷⁷Lu]Lutetium-labelled PSMA ligand-induced remission in a patient with metastatic prostate cancer.
    Kratochwil C; Giesel FL; Eder M; Afshar-Oromieh A; Benešová M; Mier W; Kopka K; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2015 May; 42(6):987-8. PubMed ID: 25573634
    [No Abstract]   [Full Text] [Related]  

  • 11. Whole-Body Integrated [
    Guberina N; Hetkamp P; Ruebben H; Fendler W; Grueneisen J; Suntharalingam S; Kirchner J; Puellen L; Harke N; Radtke JP; Umutlu L; Hadaschik BA; Herrmann K; Forsting M; Wetter A
    Mol Imaging Biol; 2020 Jun; 22(3):788-796. PubMed ID: 31482413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography/magnetic resonance imaging with 68Gallium-labeled ligand of prostate-specific membrane antigen: promising novel option in prostate cancer imaging?
    Maurer T; Beer AJ; Wester HJ; Kübler H; Schwaiger M; Eiber M
    Int J Urol; 2014 Dec; 21(12):1286-8. PubMed ID: 25047368
    [No Abstract]   [Full Text] [Related]  

  • 13. Will GRPR Compete with PSMA as a Target in Prostate Cancer?
    Iagaru A
    J Nucl Med; 2017 Dec; 58(12):1883-1884. PubMed ID: 28970333
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging.
    Kabasakal L; Demirci E; Ocak M; Akyel R; Nematyazar J; Aygun A; Halac M; Talat Z; Araman A
    Nucl Med Commun; 2015 Jun; 36(6):582-7. PubMed ID: 25738559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceleration of PSMA-Targeted Theranostics to the Clinic: Can Common Sense Prevail?
    Czernin J; Eiber M
    J Nucl Med; 2017 Aug; 58(8):1186-1187. PubMed ID: 28473599
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostate-Specific Membrane Antigen: The Target of the Decade, from Biochemical Recurrence to Widespread Adoption.
    Hofman MS
    J Nucl Med; 2020 Dec; 61(Suppl 2):246S-247S. PubMed ID: 33293445
    [No Abstract]   [Full Text] [Related]  

  • 17. Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer.
    Aggarwal R; Wei X; Kim W; Small EJ; Ryan CJ; Carroll P; Cooperberg M; Evans MJ; Hope T
    Eur Urol Oncol; 2018 May; 1(1):78-82. PubMed ID: 31100231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of (
    Yilmaz U; Komek H; Can C; Altindag S
    Ann Nucl Med; 2019 Aug; 33(8):545-553. PubMed ID: 31069696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theranostics for Advanced Prostate Cancer: Current Indications and Future Developments.
    Farolfi A; Fendler W; Iravani A; Haberkorn U; Hicks R; Herrmann K; Walz J; Fanti S
    Eur Urol Oncol; 2019 Mar; 2(2):152-162. PubMed ID: 31017091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bridging the Imaging Gap: PSMA PET/CT Has a High Impact on Treatment Planning in Prostate Cancer Patients with Biochemical Recurrence-A Narrative Review of the Literature.
    Ekmekcioglu Ö; Busstra M; Klass ND; Verzijlbergen F
    J Nucl Med; 2019 Oct; 60(10):1394-1398. PubMed ID: 30850500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.